Psychiatric comorbidity in the evolution from migraine to medication overuse headache

Cephalalgia

Volumn 25, Issue 7, 2005, Pages 519-522

  Radat, F ^a,c   Creac'h, C ^a   Swendsen, J D ^b   Lafittau, M ^b   Irachabal, S ^b   Dousset, V ^a   Henry, P ^a  

^a BORDEAUX UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c HÔPITAL PELLEGRIN   (France)

Author keywords

Comorbidity; Medication overuse headache; Migraine; Psychiatric disorder

Indexed keywords

ALCOHOL; ANALGESIC AGENT; ANTIMIGRAINE AGENT; BENZODIAZEPINE DERIVATIVE; CAFFEINE; CODEINE; ERGOT ALKALOID; ILLICIT DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; NORAMIDOPYRINE; PARACETAMOL; PSYCHOTROPIC AGENT; SEROTONIN AGONIST;

ADDICTION; ADOLESCENT; ADULT; ANXIETY DISORDER; ARTICLE; COMORBIDITY; COMPARATIVE STUDY; DEPRESSION; DISEASE COURSE; DISEASE TRANSMISSION; DRUG INDUCED HEADACHE; FAMILY HISTORY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MIGRAINE; MOOD DISORDER; RISK FACTOR;

ADOLESCENT; ADULT; COMORBIDITY; DISEASE PROGRESSION; FEMALE; FRANCE; HEADACHE DISORDERS; HUMANS; MALE; MENTAL DISORDERS; MIGRAINE DISORDERS; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 21244473702     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2005.00910.x     Document Type: Article

References (16)

1. Breslau N, Rasmussen BK. The impact of migraine. Epidemiology, risk factors, and co-morbidities? Neurology 2001; 56:S4-S12.
2. Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 2nd Edition. Cephalalgia 2004; 24 (Suppl. 1):1-152.
3. Diener HC, Dahlof CGH. Headaches associated with chronic use of substances. In: Olesen J, Tfelt-Hansen P, Welch KMA, editors. Headaches, 1st edn. New York: Raven Press Ltd, 2000:721-7.
4. Lucas C, Lanteri-Minet M, Leroy L. FRAMIG 99: comportements thérapeutiques des migraineux. Rev Neurol 2000; 156 (Suppl. 1):134.
5. Mathew NT, Stubits E, Nigam MP. Transformation of episodic migraine into daily headache: analysis of factors. Headache 1982; 22:66-8.
6. Radat F, Sakh D, Lutz G, El Amrani M, Ferreri M, Bousser MG. Psychiatric comorbidity is related to headache induced by chronic substance use in migraineurs. Headache 1999; 39:477-80.
7. Mitsikostas DD, Thomas AM. Comorbidity of headache and depressive disorders. Cephalalgia 1999; 19:211-07.
8. Swendsen JD, Conway KP, Rounsaville BJ, Merikangas KR. Are personality traits familial risk factors for substance use disorders? Results of a controlled family study. Am J Psychiatry 2002; 159:1760-6.
9. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. DSM-IV, 4th edn. Washington DC: American Psychiatric Press, 1994.
10. Sheehan DV, Lecrubier Y, Sheehan KH, Amorin P. The Mini International Neuropsychiatric Interview (MINI): the development and validation of a structure diagnostic interview for DSM IV and ICD. J Clin Psy 1988; 59 (S20):22-33.
11. Endicott J, Andreasen N, Spitzer RL. Family history research diagnostic criteria, 3rd edn. Biometric research. New York: New York State Psychiatric Institute, 1978.
12. Radat F, Irachabal S, Creac'h C, Dousset V, Sibrac MC, Swendsen JD et al. Nosological problems in assessing abuse in migraine patients: preliminary results of a neuropsycho-physiological study. Cephalalgia 2001; 21:466.
13. Lipton RB, Stewart WF. Migraine headaches. Epidemiology and comorbidity. Clin Neurosci 1998; 5:2-9.
14. Merikangas KR, Angst J. Migraine and psychopathology, results of the Zurich Cohort Study of Young adults. Arch General Psychiatr 1990; 47:849-53.
15. Breslau N, Davis GC, Andreski P. Migraine, psychiatric disorders, and suicide attempts: an epidemiologic study of young adults. Psychiatry Res 1991; 37:11-23.
16. Michultka DM, Blanchard EB, Appelbaum KA. The refractory headach patient. II High medication consumption headache. Behav Res Ther 1987; 27:411-20.